Replies to post #344385 on NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

Yeah, shocking isn’t it! Well, we do have someone named Larry Smith’s take on things. Of course, he got his tip from the Hub so...


“The obvious read is that NWBO submitted its SAP to the NHS and PIE and sought to have mOS become the primary endpoint”

[10baggerz]

So the SAP changes made by the REGULATORY AGENCIES in the UK and EU are a “complete and total fabrication”?

I try to understand you because you do a good job pointing out the very real past issues with NWBO management, and it helps keep me from falling in love with the stock. People like you have saved me lots of money before on other stocks.

However, you never explain why these RAs bought in to the new SAP. If you can provide me with the “bear perspective” on that it would be appreciated, because I don’t think there is one. That is why I am very long and not planning on selling anytime soon.

NOTE: Spare me the split SAP argument (I get it and yes it’s a possibility). I’m specifically asking why UK/EU changes are not bullish. Can you at least admit that? IMO that is the one of the best giveaways of all time that a trial will meet its primary endpoint (at the very least in Europe).